Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sanjai Rao

Psychiatry San Diego, CA Medical Doctor

NPI 1700993557 CMS profile 77194

3350 Via La Jolla San Diego, San Diego, CA 92161

Open in the dashboard

General payments

$445,230

400 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sanjai Rao of San Diego, CA is reported in the CMS Open Payments database as having received $445,230 across 400 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $16,823 13
2024 General $68,195 62
2023 General $68,700 51
2022 General $106,769 78
2021 General $46,971 40
2020 General $54,634 50
2019 General $83,137 106

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sanjai Rao
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Sanjai Rao were reported at $16,823. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Sanjai Rao Psychiatry median Middle half National median
2019 $83,137 $184 $59–$605 $163
2020 $54,634 $119 $36–$372 $114
2021 $46,971 $143 $43–$576 $132
2022 $106,769 $153 $50–$590 $149
2023 $68,700 $170 $56–$651 $160
2024 $68,195 $179 $57–$673 $164
2025 $16,823 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $252,327 231 payments
  2. Alkermes, Inc. $81,332 73 payments
  3. Neurocrine Biosciences, Inc. $77,723 64 payments
  4. Janssen Scientific Affairs, LLC $11,675 3 payments
  5. Otsuka Pharmaceutical Development & Commercialization, Inc. $7,765 15 payments
  6. ITI, Inc. $4,628 2 payments
  7. Sunovion Pharmaceuticals Inc. $4,486 7 payments
  8. E.R. Squibb & Sons, L.L.C. $2,709 2 payments
  9. Otsuka America Pharmaceutical, Inc. $2,550 2 payments
  10. Johnson & Johnson Health Care Systems Inc. $36 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $342,273 165 payments
  2. Consulting Fee $54,972 24 payments
  3. Travel and Lodging $38,008 84 payments
  4. Food and Beverage $9,977 127 payments
Products named General payments · program years 2019–2025
  1. INVEGA SUSTENNA $233,052 203 payments
  2. INVEGA TRINZA $216,416 175 payments
  3. ARISTADA Cns $67,983 62 payments
  4. ARISTADA Cns $67,983 62 payments
  5. ARISTADA Cns $67,983 62 payments
  6. ARISTADA Cns $67,983 62 payments
  7. ARISTADA INITIO $58,298 49 payments
  8. INGREZZA $56,575 45 payments
  9. LYBALVI $23,034 24 payments
  10. SPRAVATO $19,214 29 payments
  11. Other $75,340 68 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

400 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record